Medical devices, new developments and concerns

Slides:



Advertisements
Similar presentations
Lessons Learned in Social Protection in health Group 8.
Advertisements

World Health Organization
Addressing Quality and Safety Standards of Kenyan Production
IAEA International Atomic Energy Agency HPS Annual Meeting Current Situation and Future Challenges on Occupational Radiation Protection in Latin America.
Rational Use of Injections within National Drug Policies World health organisation Essential Drugs and Medicines Policy Safe Injection Global Network Cairo.
PSM landscape, IHP+ June 2014, Geneva 1 |1 | Procurement and Supply Management Landscape of existing investments and priorities Lisa Hedman Department.
SUPPLY AND PROCUREMENT CHALLENGES: ASSISTIVE PRODUCTS IN EMERGENCIES AND LOW-RESOURCE SETTINGS Shauna Mullally, Technical Specialist for Medical Devices.
SPECIAL CONSIDERATION FOR PESTICIDES Jim Hester Agency Environmental Coordinator.
Process of Development of Five Year Strategic Plan for Child Health Development Dr Myint Myint Than Deputy Director (WCHD) Department of Health.
Outcomes of Public Health
Update and future directions for prequalification of medicines WHO HQ, Geneva, 4 February 2008 Dr Lembit Rägo Coordinator Quality Assurance and Safety:
IAEA International Atomic Energy Agency Senior Regulators Meeting Technical Cooperation Programme Supporting Radiation Safety Infrastructure in Member.
XXX_DECRIPT_MON00/1 Quality and impact of Social Science and Operations Research by the Special Programme in Human Reproduction Department of Reproductive.
1 Department of Medicines Policy and Standards, Health Technology and Pharmaceuticals WHO’s Role in Assuring the Quality Safety and Efficacy of Medicines:
Existing Challenges – POC Introduction Lab Technical Working Group Jason Williams, Principal Laboratory Advisor, SCMS January 20-21, 2013.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:
Policy track summary ICIUM 2011 – 18 Nov Policy track topics 1.The pharmaceutical policy process 2.Quality and safety of medicines in LMIC 3.Policy.
04_DirectorReport_PCC/1 9/2004 Rita Kabra_/1 Access to essential medicines for Maternal and Newborn Health Dr Rita Kabra Making Pregnancy Safer WHO/EDM.
1 Pharmaceutical System Strengthening: Is There a Need for a New Paradigm? Douglas Keene, PharmD, MHS ICIUM-3 Pre-Conference Session 14 November 2011.
Towards a Central Africa Trade Facilitation Strategy: Customs union and Policy Dialogue BBL – September 29 th 2011.
Public Policy towards Public- Private Collaboration in Strengthening Health Systems World Bank Commitments and Challenges Donor Forum Paris, May
3rd WHO Prequalification Stakeholders Meeting :Diagnostics 3rd Stakeholders Meeting on Prequalification Geneva, 4th February 2008 Update on Prequalification.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
1 |1 | Regulatory authority and Immunization programs: a joint work for patient safety Global Vaccine Safety Group Department of Essential Medicines and.
Universal health coverage and its place in protecting family life CIAMS XIX World Congress, September 2014 Annette Mwansa Nkowane, RN, RM, Bsc, MA.
Global Clinical Engineering Success Stories Establishment of National Health Technology Management System for Public Hospitals Name: Bilal BECEREN Affiliation:
Quality Improvement An Introduction
Non-communicable diseases in Afghanistan
Health Technology Assessment
Investing in the Breastfeeding Movement in India
TOPIC: THE VALUE OF BIOMEDICAL ENGINEERS AND TECHNICIANS IN HOSPITAL PRESANTED BY: KWIZERA ABRAHAM STUDENT IN: BMET /FINALIST STU INSTITUTION: IPRC KIGALI.
Surveillance of NCDs: Instruments and Data Sources
Journey For Scaling up Family Practice
Unit for Medical Systems and Devices at Ministry of Health
Regional Road Safety Workshop African Development Bank,
Evidence-based Medicine
Development of the detailed Nutrition Response Plan
WHO Medicines Work in Countries: The Kenya Example
GARD/NCD Action Plan & 2011 UN Summit on NCDs
ISO 9000.
What are ISO 9000 Standards? ISO 9000 Standards
Need for ISO 9000 & other Q Systems Swamynathan.S.M AP/ECE/SNSCT
Training Perspectives for Developing Countries
2018 UN flagship report on disability and development overview of work
World Health Organization
Raffaella Ravinetto, Chair
MACROECONOMICS AND HEALTH
‘universal health coverage for all’
World Health Organization
Integrating HTA into Public Health Policies
Health Technology Assessment for Universal Health Coverage
Importance OF CAUSE OF DEATH DATA
MANAGEMENT, STAFF, NATIONAL COALITION, FINANCIAL RESOURCES,
WHO’s Role in Assuring the Quality Safety and Efficacy of Drugs:
Supporting Implementation of the EDL
Dr Manisha Shridhar Regional Advisor WHO-SEARO
Technical Specifications of Medical Devices
Proposed Regional Medium-term Civil Registration and Vital Statistics Plan First Conference of African Ministers Responsible for Civil Registration August.
Innovation of medical devices , WHO
Towards International Harmonized Nomenclature for Medical Devices
DIFFERENT MEANINGS OF COST
Title : Quality data for efficient management - lessons from the UNRWA Health Procurement Strengthening Project   Abstract: Introduction :UNRWA has been.
Medical devices for NCDs
WHO methodology for the selection of priority medical devices for NCD management Medical technologies for essential cardiovascular, stroke, diabetes, and.
WHO Department of Essential Medicines and Health Products
An Enabling Business Environment and A Strategic Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
Objective of the workshop
Annie Namala WADA NA TODO ABHIYAN
An Enabling Business Environment and A Strategy and Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
National Hospice and Palliative Care Organization’s Palliative Care Resource Series Best Practices for Using Telehealth in Palliative Care Vicki Wildman,
Presentation transcript:

Medical devices, new developments and concerns IPC Adriana Velazquez Essential Medicines and Health Products Department

Medical Devices New development and concerns Priority medical devices For Reproductive Maternal New born and Child, 2015 For NCDs, Cancer management Technical specifications for procurement Challenges Nomenclature of medical devices Current situation and problems Way forward

SDG3: Achieve universal health coverage, including financial risk protection, access to quality essential health-care services

Policies, Country profiles, Human resources, Innovation and Regulations of medical devices.

Health technology Assessment, Health technology management and lists of priority medical devices.

Priority medical devices through the continuum of care

Methodology to select medical devices, (Cancer 2015)

General (for all interventions) and specialized medical devices

Medical devices required to perform interventions according to guidelines.

Technical specifications for procurement are indispensable for good health services. Problems, lack of good technical specifications: Increase: costs, corruption, possibility of getting bad quality products, or not compatible to setting or inappropriate. Bad bidding process with not appropriate TS lead to: Lack of right consumables, Equipment not being installed Human resources not trained Warranties not available Maintenance not performed…etc. Consequences: misdiagnose, mistreatment, delay in service provision, bad quality and unsafe Outcome: Patient’s health in risk of becoming complicated Patient need to pay costly out of pocket to get health service urgent.

Technical specifications, WHO actual template Name and coding General use Technical characteristics Physical characteristics Technical Energy source Accesories-spare parts-consumables Bidding/procurement terms/donation requirements Standards and safety Training and installation Warranty and maintenance Documentation

Name and coding: Lack of Nomenclature of medical devices cause confusion and health provision problems Lack of global public nomenclature Multiple nomenclature systems coexist Confusion, lack of synergy Copyright nomenclatures, not public good Different systems are being used, even inside countries or by procurement agencies There is no link between regulation and management ( supply chain) and maintenance. Different systems in WHO, UN organizations and health tech providers

July 2014 status of nomenclature for medical devices globally

General statistics of different nomenclature systems in 175 MS

Conclusions The needs to define a way forward to: Disseminate the list of priority medical devices Disseminate the list of priority assistive devices Develop technical specifications for all these products, to increase availability in the market and better health service provision. Work on technical specifications in a harmonized way using same template across UN agencies, adapted to type of technology. Define the strategies to have a common publicly available nomenclature of medical devices (similar to the INN).